0001968582-24-000368.txt : 20240513
0001968582-24-000368.hdr.sgml : 20240513
20240513171451
ACCESSION NUMBER: 0001968582-24-000368
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240513
DATE AS OF CHANGE: 20240513
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexeo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001907108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 854012572
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 24940306
BUSINESS ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: (212) 547-9879
MAIL ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Townsend Richard Nolan
CENTRAL INDEX KEY: 0001995218
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O LEXEO THERAPEUTICS, INC.
STREET 2: 345 PARK AVENUE SOUTH, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
144
1
primary_doc.xml
144
0001995218
XXXXXXXX
LIVE
0001907108
Lexeo Therapeutics, Inc.
001-41855
345 Park Avenue, Floor 6
New York
NY
10010
212-547-9879
Richard Nolan Townsend
Director
Officer
Common Stock
J.P. Morgan Securities LLC
390 Madison Avenue
6th Floor
New York
NY
10017
70000
927500
32945341
05/13/2024
NASDAQ
Common Stock
05/14/2021
Stock Option Exercise
Issuer
N
50000
05/14/2021
Cash
Common Stock
05/13/2024
Stock Option Exercise
Issuer
N
20000
05/13/2024
Cash
Y
Some of the shares covered by this filing are stock options that will be exercised within 3 months from the date of this filing.
05/13/2024
12/19/2023
/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Richard Nolan Townsend